baber/WOPTO huggingface dataset:
Patent AU-2021254557-A1 (AU)
Title: Suture anchor construct and deployment device
Inventor: ALFONSO GREGORY A
IPC: A61B17/00
Filed: 2021-10-19
Abstract: A soft suture anchor construct is provided for placement in or against tissue or bone.  
The anchor includes an all-suture anchor having two ends positioned in a first direction in a 
pre-deployment configuration. In a deployed configuration, the two ends are positioned in a 
second direction different from the first direction. The suture anchor construct also includes a 
filament passing through the anchor at a plurality of passing locations, where the filament 
changes direction at least once along the direction of the longitudinal axis of the anchor and 
forms at least one slack line. In the pre-deployment configuration, the filament extends a first 
length between adjacent passing locations, and in the deployed configuration, the filament 
extends a second length between adjacent passing locations. The second length is shorter than 
the first length. The suture anchor construct may be deployed in a bone hole with an inserter, 
anchor driver, or other deployment device.  
17 
18167992_1 (GHMatters) P45713AU01
Patent AU-2021264332-A1 (AU)
Title: A radar system having a photonics-based signal generator
Inventor: ZHANG ZIQIAN
IPC: H04B10/70
Filed: 2021-04-30
Abstract: The present application relates to radio detection and ranging (radar) systems and, in particular, to a radar system having a photonics-based signal generator. Such a radar system comprises a stepped-frequency optical signal generator, an optical-to-electrical converter, and a transmitter. The stepped-frequency optical signal generator is configured for converting an optical signal into a stepped-frequency optical signal. The optical-to-electrical converter for converting the stepped-frequency optical signal into a stepped-frequency electrical signal. The transmitter for transmitting a microwave signal based on the stepped-frequency electrical signal.
Patent AU-2021286270-A1 (AU)
Title: Double overmolded display housing assembly
Inventor: BEER JOSHUA M
IPC: H02J7/00
Filed: 2021-12-14
Abstract: A display housing assembly has a base, a lens, and buttons. The base, lens, and 
buttons may be shaped to correspond with an external geometry of a tool housing, such as, 
for example, curved, arcuate or cylindrically shaped. The display housing assembly may also 
be assembled by molding the lens, molding the base over the lens, and molding the buttons 
over the base.  
18327652_1 (GHMatters) P117924.AU
1/6 
&C 
tC
Patent AU-2021290257-A1 (AU)
Title: Globin gene therapy for treating hemoglobinopathies
Inventor: SADELAIN MICHEL
IPC: C12N15/11
Filed: 2021-12-21
Abstract: The presently disclosed subject matter provides for expression cassettes that allow for 
expression of a globin gene or a functional portion thereof, vectors comprising thereof, and cells 
transduced with such expression cassettes and vectors. The presently disclosed subject matter 
further provides methods for treating a hemoglobinopathy in a subject comprising administering 
an effective amount of such transduced cells to the subject.
Patent AU-2021293931-A1 (AU)
Title: SARS-CoV-2 immunodominant peptides and uses thereof
Inventor: KULA TOMASZ
IPC: A61K38/00
Filed: 2021-06-17
Abstract: Provided herein are methods and compositions for the treatment and/or prevention of COVID-19 through the induction of an immune response against identified SARS-COV-2 immunodominant peptides.
Patent AU-2021296848-A1 (AU)
Title: Engineered hepatitis B virus neutralizing antibodies and uses thereof
Inventor: ROSEN LAURA
IPC: C07K16/08
Filed: 2021-06-23
Abstract: The present disclosure relates, in part, to antibodies, and antigen-binding fragments thereof, that can bind to the antigenic loop region of hepatitis B surface antigen (HBsAg) and,optionally, can neutralize infection hepatitis B virus (HBV), and further optionally, of hepatitis delta virus (HDV). Presently disclosed antibodies and antigen-binding fragments have advantageous production characteristics, such as reduced formation of aggregates and/or improved production titer in transformed host cells, as compared to a reference antibody or antigen-binding fragment. The present disclosure also relates to to fusion proteins that comprise an antigen-binding fragment, and to nucleic acids that encode and cells that produce such antibodies, antigen-binding fragments, and fusion proteins. In addition, the present disclosure relates to the use of the antibodies, antigen-binding fragments, fusion proteins, and related polynucleotides, vectors, host cells, and compositions of the present disclosure in the diagnosis, prophylaxis and treatment of hepatitis B and hepatitis D. Also provided are combination therapies comprising (i) an antibody or antigen-binding fragment and (ii) an agent that is an inhibitor of HBV gene expression and/or that reduces HBV antigenic load.
Patent AU-2021306281-A1 (AU)
Title: Beads as transposome carriers
Inventor: WU YIR-SHYUAN
IPC: C12Q1/6806
Filed: 2021-07-07
Abstract: Degradable polyester bead are described comprising a plurality of transposome complexes immobilized to the surface thereof, wherein each transposome complex comprises a transposase bound to a first polynucleotide and a second polynucleotide, wherein the first polynucleotide comprises a 3' portion comprising a transposon end sequence and a tag, and the second polynucleotide comprises a 5' portion that is complementary to and hybridized to the transposon end sequence, and wherein the polyester bead has a melting point of from 50 °C to 65 °C. Flow cells and methods related to these polyester beads are described. Also described herein are compositions comprising a bead and at least one nanoparticle and methods of use of such compositions comprising transposome complexes immobilized to nanoparticles.
Patent AU-2021332355-A1 (AU)
Title: Asparagine feed strategies to improve cell culture performance and mitigate asparagine sequence variants
Inventor: BENNUN-SERRANO SANDRA
IPC: C12P21/02
Filed: 2021-08-27
Abstract: A method for culturing eukaryotic cells for improved cell culture performance is provided. The method generally comprises propagating or maintaining eukaryotic cells in a defined cell culture medium; wherein the defined cell culture medium is supplemented with asparagine in an amount from about 2.6 mM to about 43.2 mM during early fed-batch cell culture and from about 2.6 mM to about 21.6 mM during late fed-batch cell culture; and maintaining said cells in said asparagine supplemented cell culture medium for at least a portion of the early fed-batch cell culture and at least a portion of the late fed-batch cell culture; wherein the performance of the cell culture is improved by the asparagine supplementation, as compared to a similar method with a lower amount of asparagine supplementation in the early and/or late fed-batch cell culture.
Patent AU-2021358936-A1 (AU)
Title: Health assessment and monitoring system and method for clean fuel electric vehicles
Inventor: MORRISON BRIAN
IPC: G01R31/00
Filed: 2021-10-05
Abstract: System and method for fuel-cell and motor trend monitoring including recording signals from fuel-cell and motor system-condition sensors or sets of onboard sensors and periodically analyzing results to examine fuel-cell and motor system performance trends to predict the need for fuel-cell or motor system maintenance. Various analyses can be performed, separately or in parallel, including: comparing the current parameter values with recorded parameter values in previous instances of similar operating conditions; comparing parameter values to predetermined nominal ranges; and detecting sensed parameter values that exceed recommended fuel-cell or motor system operating conditions or that exhibit trends over time that if continued result in exceeding fuel-cell or motor system operating conditions or producing out-of-bound readings. Results of the analyses inform fuel-cell, motor, and aircraft system maintenance scheduling and provide alerts to users regarding recommended fuel-cell, motor, and aircraft system performance trends and/or operating condition exceedances, enhancing safety and improving maintenance efficiency.
Patent AU-2021375225-A1 (AU)
Title: Method and apparatus for assigning network address prefix
Inventor: ZHANG WEN
IPC: H04L61/5007
Filed: 2021-09-27
Abstract: Embodiments of the present disclosure provide methods and apparatuses for assigning network address prefix. A method performed by a control plane function may comprise: receiving (S101), from a terminal device, a request for assigning a network address prefix; determining (S102) whether the network address prefix is assigned by the control plane function or a user plane function; transmitting (S103), to the user plane function, a PFCP Session Modification Request for requesting the user plane function to assign the network address prefix, if it is determined that the network address prefix is assigned by the user plane function; receiving (S104), from the user plane function, a PFCP Session Modification Response including an assigned network address prefix; and transmitting (S105) the assigned network address prefix to the terminal device. The specific procedure for the terminal device to obtain the network address prefix from a network entity not directly requested by the terminal device may be defined.
Patent AU-2021409632-A1 (AU)
Title: Non-human animals having a humanized tslp gene, a humanized tslp receptor gene, and/or a humanized il7ra gene
Inventor: TANG YAJUN
IPC: C07K14/715
Filed: 2021-12-20
Abstract: Disclosed herein are rodents (such as, but not limited to, mice and rats) genetically modified to comprise a humanized Tslp gene, a humanized Tslpr gene, a humanized Il7ra gene, or a combination thereof. Compositions and methods for making such genetically modified rodents, as well as methods of using such genetically modified rodents as an animal model for diseases such as allergic diseases and cancer are provided.
Patent AU-2021438879-A1 (AU)
Title: Harq process selection
Inventor: KUO PING-HENG
IPC: H04W72/12
Filed: 2021-03-30
Abstract: Example embodiments of the present disclosure relate to de-prioritization of retransmission. A device determines whether user data is absent in a transport block that is to be retransmitted through a hybrid automatic repeat request process. The device deprioritizes selection of the hybrid automatic repeat request process for one or more transmissions on a configured grant based at least in part on the determination. Through this solution, it is possible to avoid or deprioritize unnecessary retransmissions of the transport blocks without user data.
Patent WO-2022192933-A1 (WO)
Inventor: DAY MAXWELL WILLIAM
IPC: A45B19/08
Filed: 2022-03-02
Abstract: A hinged joint is described for connecting an outer housing frame member to an inner housing frame member, the hinged joint comprising an outer housing associated with the outer housing frame member, the outer housing having an elongate seat disposed between opposing side walls, and a hinge pin supported by each of said side walls; an inner housing associated with an inner housing frame member, the inner housing being at least partially receivable on the elongate seat of the outer housing, the hinge pin being operatively locatable in a hinge pin guide of the inner housing, the hinge pin guide having a locking guide part and an unlocking guide part, wherein movement of the outer housing is in association with movement of the hinge pin in the hinge guide of the inner housing. Frames comprising a plurality of frame members connected by the hinged joint are also described.
Patent AU-2022200351-A1 (AU)
Title: Method for inactivating ZIKA Virus and related methods
Inventor: LIVENGOOD JILL
IPC: A61P31/14
Filed: 2022-01-19
Abstract: The present disclosure relates to methods for inactivating a Zika virus which can be used in 
vaccines and immunogenic compositions. The present disclosure also relates to a method for 
determining the completeness of inactivation of an arbovirus preparation and to a method for 
determining the residual formaldehyde content in a pharmaceutical composition comprising 
an inactivated virus.
Patent AU-2022201754-A1 (AU)
Title: Message and system for application function influence on traffic routing
Inventor: LI XU
IPC: H04L41/04
Filed: 2022-03-14
Abstract: An aspect of the disclosure provides for a method for user equipment (UE) internet 
protocol (IP) address management. The method includes sending by an application function 
(AF), a request to a policy control function (PCF), the request including information identifying 
traffic and an indication that a UE IP address associated with the traffic should be preserved.  
The method further includes sending by the PCF, to a session management function (SMF) 
being responsible for managing a Protocol Data Unit (PDU) session associated with the traffic, 
a policy and charging control (PCC) rule including the indication. In some embodiments, the 
request is sent by the AF to the PCF via a network exposure function (NEF). In some 
embodiments, the method further includes managing, by the SMF, the UE IP address according 
to the PCC rule. In some embodiments, the managing includes preserving the UE IP address for 
a PDU session associated with the traffic. In some embodiments, the preserving includes 
preventing reselection of a protocol data unit (PDU) session anchor (PSA) to which the UE IP 
address is associated.
Patent AU-2022203881-A1 (AU)
Title: Outdoor walking equipment
Inventor: YANG DEZHONG
IPC: A01D34/82
Filed: 2022-06-03
Abstract: A riding lawn mower, including: a frame; a seat; a walking assembly and a walking motor; a 
cutting assembly and a driving motor configured to drive the cutting assembly; a first energy 
storage device configured to supply power to at least one of the walking motor or the driving 
motor, the first energy storage device including at least one first energy storage unit, the first 
energy storage device detachably mounted to the frame and enabled to supply power to a 
handheld power tool when detached from the riding lawn mower; and a second energy storage 
device configured to supply power to at least one of the walking motor or the driving motor, the 
second energy storage device including at least one second energy storage unit; wherein an 
energy density of the second energy storage unit is different from an energy density of the first 
energy storage unit.  
Up 
Right Back 
Front Left 
Down 
112 
100a O 1 
12O 
142 
FlG.1
Patent AU-2022207836-A1 (AU)
Title: Method and apparatus for managing wireless connection of electronic device
Inventor: CHUNG SEUNGTAEK
IPC: H04W76/14
Filed: 2022-01-05
Abstract: An electronic device comprises: a communication module which supports a wireless communication connection; at least one processor operatively connected to the communication module; and a memory operatively connected to the at least one processor, wherein the memory may store instructions which, upon execution, allow the at least processor to establish a channel connection with an external electronic device through the communication module, obtain information about the external electronic device, determine, on the basis of the information about the external electronic device, the maximum allowed number of connections of the external electronic device or whether to carry out broadcasting of the external electronic device, and transmit, to the external electronic device, configuration information including at least one of the determined maximum allowed number of connections or whether to carry out the broadcasting. Various other embodiments identified by the specification are also possible.
Patent AU-2022209328-A1 (AU)
Title: Pharmaceutical combinations
Inventor: FERRETTI STEPHANE
IPC: A61K39/00
Filed: 2022-07-28
Abstract: 5 
The present invention relates to a pharmaceutical combination which comprises (a) at 
least one antibody molecule (e.g., humanized antibody molecules) that bind to Programmed 
Death 1 (PD-1), and (b) a HDM2-p53 interaction inhibitor, said combination for 
simultaneous, separate or sequential administration for use in the treatment of a proliferative 
0 disease, a pharmaceutical composition comprising such combination; a method of treating a 
subject having a proliferative disease comprising administration of said combination to a 
subject in need thereof; use of such combination for the treatment of proliferative disease; 
and a commercial package comprising such combination; said proliferative disease being a 
TP53 wildtype tumor, in particular TP53 wildtype renal cell carcinoma (RCC) or TP53 
5 wildtype colorectal cancer (CRC).  
10
Patent AU-2022209692-A1 (AU)
Title: Intraoral diagnostic device and method of using same
Inventor: SUBHASH HREBESH MOLLY
IPC: A61B1/00
Filed: 2022-01-06
Abstract: An intraoral device (100) for determining oral health characteristics is provided. The device includes a light source (106) configured to emit light in a plurality of wavelengths within or about the oral cavity and a matrix array multispectral sensor (102) configured to detect a plurality of spectral channels of a spectral image. Each of the plurality of spectral channels may allow transmission of a corresponding wavelength. The device may include a processor (1100) configured to identify the detected plurality of spectral channels of the spectral image relating to the oral cavity. Based on the detected plurality of spectral channels, the processor may cause the light source to adjust the light emitted within or about the oral cavity to modify a signal to noise ratio and/or an image calibration of a subsequent spectral image. The matrix array multispectral sensor may capture the subsequent spectral image relating the oral cavity in the adjusted emitted light.
Patent AU-2022214311-A1 (AU)
Title: Cyclic flow apparatus
Inventor: WILLIS KLENTON T
IPC: F04B9/02
Filed: 2022-01-28
Abstract: The cyclic flow apparatuses consistent with the technology disclosed herein are configured to sealably couple to a liquid flow circuit. The cyclic flow apparatus is configured to change a flow velocity of a liquid through a filter media holder. In various embodiments, the cyclic flow apparatus is configured to change the flow velocity of the liquid through a portion of the liquid flow circuit. The cyclic flow apparatus can be configured to cyclically change the flow velocity of the liquid in the liquid flow circuit through the filter media holder.
Patent AU-2022215028-A1 (AU)
Title: Solid pharmaceutical compositions and methods of producing the same
Inventor: PUCHKOV MAXIM
IPC: A61K9/50
Filed: 2022-01-26
Abstract: The invention relates to a method for the production of templated carrier particles with primary and secondary internal structures comprising the steps of a) combining a carrier material with a template material, wherein the carrier material forms primary structures and secondary internal structures; b) transforming the template material; c) removing the transformed template material; and d) obtaining carrier particles with secondary internal structures. Further, the invention relates to a carrier particle with secondary internal structures obtainable by the method according to the invention. The method of the invention can further be used for the production of a compacted carrier matter, by further comprising a step of compacting the carrier particles with secondary internal structures to obtain the compacted carrier matter. Furthermore, the invention relates to a solid pharmaceutical composition comprising the carrier particle or the compacted carrier matter produced according to the method of the invention.
Patent AU-2022225831-A1 (AU)
Title: Heat exchange reactor
Inventor: FAKA SOLOMON
IPC: F28D7/00
Filed: 2022-02-25
Abstract: A reactor comprising: a shell enveloping: a reaction zone, a heat transfer zone, and an isolation zone; the shell provided with: a feed fluid inlet, a product fluid outlet, and an isolation fluid inlet. The reaction zone provides fluid communication between the feed fluid inlet and the product fluid outlet, and extends though the heat transfer zone and the isolation zone. The isolation zone is located between the heat transfer zone and the product fluid outlet; wherein a feed fluid as it flows from the feed fluid inlet, through the reaction zone is heated by a heat transfer fluid flowing through the heat transfer zone and reacts to form a product fluid that flows out of the shell through the product fluid outlet. A purge fluid in the isolation zone is at a positive pressure relative to a pressure of the heat transfer fluid flowing through the heat transfer zone.
Patent AU-2022260558-A1 (AU)
Title: Use of apoptosis inhibitors for cold storage of blood platelets
Inventor: BAKCHOUL TAMAM
IPC: A01N1/00
Filed: 2022-04-22
Abstract: The present invention relates to a pharmaceutical composition for cold storing blood platelets, comprising platelets in a suitable storage medium, and at least one inhibitor of platelet apoptosis. Preferably, said apoptosis inhibitor is a selective inhibitor targeting cold-storage induced apoptosis.
Patent AU-2022266583-A1 (AU)
Title: Anti-adgre2 antibodies and uses thereof
Inventor: BANERJEE ANTARA
IPC: C07K16/28
Filed: 2022-04-25
Abstract: Antibodies, fragments thereof and fusion proteins that specifically bind to ADGRE2, are described, as well as methods of making and using such antibodies. Such antibodies, fusion proteins and fragments thereof are useful for the treatment and diagnosis of various autoimmune diseases and cancers, including, for example, acute myeloid leukemia.
Patent AU-2022271428-A1 (AU)
Title: Nickel-cobalt precipitation method for nickel laterite ore acid leaching solution after iron and aluminium removal
Inventor: LIU CHENG
IPC: C22B3/44
Filed: 2022-11-16
Abstract: The present disclosure provides a nickel-cobalt precipitation method for nickel laterite ore acid 
leaching solution after iron-aluminium removal. The above precipitation method includes: S100, 
adding a reducing agent to the post iron-aluminium removal solution; S200, continuously feeding 
the mixed solution into a reactor to perform an alkali conversion precipitation reaction; S300, 
continuously performing a dense separation treatment on the precipitation slurry; S400, adding a 
precipitation inducer to a part of an overflow so as to perform the alkali conversion reaction, then 
mixing and homogenizing the alkali conversion overflow and the first part of an underflow; or, 
adding the precipitation inducer to the first part of the underflow so as to perform the alkali 
conversion reaction; S500, continuously feeding the alkali conversion crystal slurry into the reactor; 
and S600, filtering and washing the second part of the underflow and obtain a mixed hydroxide 
precipitate product.
Drawings 
S100 
Add a reducing agent to the nickel laterite ore acid 
leaching solution after iron-aluminium removal and mix to 
form a mixed solution 
i 
S200 
Continuously feed the mixed solution into a reactor so as 
to perform an alkali conversion precipitation reaction to 
obtain a precipitation slurry 
S300 
Continuously perform a dense separation treatment on the 
precipitation slurry and obtain an underflow and an overflow 
and divide the underflow into a first part and a second part 
S400 
Add a precipitation inducer to a part of the overflow so as to 
perform the alkali conversion reaction and obtain an alkali 
conversion overflow, then mix and homogenize the alkali 
conversion overflow and the first part of the underflow, to form 
alkali conversion crystal slurry 
S500 
Continuously feed the alkali conversion crystal slurry 
into the reactor to participate in an alkali conversion 
precipitation reaction 
S600 
Sequentially filter and wash the second part of the 
underflow to obtain a mixed hydroxide precipitate 
(MHP) product 
Fig. 1 
1/7
Patent AU-2022276188-A1 (AU)
Title: Polypeptides related to hmgb1 useful for promoting tissue regeneration, compositions comprising same, and uses thereof
Inventor: NANCHAHAL JAGDEEP
IPC: C07K14/47
Filed: 2022-05-19
Abstract: This invention provides polypeptides represented by the following formula: H